Avilar Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States
Avilar Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $75 million sold in a notice filed in 2023.
Avilar Therapeutics at a glance
What does Avilar Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $75.3 million sold (2023).
Frequently asked questions about Avilar Therapeutics
Where is Avilar Therapeutics headquartered?
Avilar Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Avilar Therapeutics do?
Avilar Therapeutics, Inc. is a pharmaceutical company.
When was Avilar Therapeutics founded?
The earliest incorporation on record for Avilar Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences